Cargando…
TGFβ Signaling in the Pancreatic Tumor Microenvironment
SIMPLE SUMMARY: There is currently no effective treatment for patients with advanced pancreatic ductal adenocarcinoma (PDAC). Transforming Growth Factor β (TGFβ) signaling has been implicated in several hallmark features of PDAC pathobiology, and TGFβ inhibitors are beginning to show promise in the...
Autores principales: | Principe, Daniel R., Timbers, Kaytlin E., Atia, Luke G., Koch, Regina M., Rana, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533869/ https://www.ncbi.nlm.nih.gov/pubmed/34680235 http://dx.doi.org/10.3390/cancers13205086 |
Ejemplares similares
-
Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer
por: Principe, Daniel R., et al.
Publicado: (2022) -
Leukocyte subtyping predicts for treatment failure and poor survival in anal squamous cell carcinoma
por: Principe, Daniel R., et al.
Publicado: (2022) -
The role of TGF-β in the tumor microenvironment of pancreatic cancer
por: Luo, Qiang, et al.
Publicado: (2022) -
TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment
por: Chung, Jeff Yat-Fai, et al.
Publicado: (2021) -
TGF-β signaling in the tumor metabolic microenvironment and targeted therapies
por: Shi, Xueke, et al.
Publicado: (2022)